PMID- 37346078 OWN - NLM STAT- MEDLINE DCOM- 20230626 LR - 20231116 IS - 1178-2005 (Electronic) IS - 1176-9106 (Print) IS - 1176-9106 (Linking) VI - 18 DP - 2023 TI - Physical Activity, Exercise Capacity and Sedentary Behavior in People with Alpha-1 Antitrypsin Deficiency: A Scoping Review. PG - 1231-1250 LID - 10.2147/COPD.S389001 [doi] AB - Alpha-1 antitrypsin deficiency (AATD) is a hereditary disorder and a genetic risk factor for chronic obstructive pulmonary disease (COPD). Physical activity (PA) is important for the prevention and treatment of chronic disease. Little is known about PA in people with AATD. Therefore, we aimed to map the research undertaken to improve and/or measure PA, sedentary behaviour (SB) or exercise in people with AATD. Searches were conducted in CINAHL, Medline, EMBASE and clinical trial databases for studies published in 2021. Databases were searched for keywords (physical activity, AATD, exercise, sedentary behavior) as well as synonyms of these terms, which were connected using Boolean operators. The search yielded 360 records; 37 records were included for review. All included studies (n = 37) assessed exercise capacity; 22 studies reported the use of the six-minute walk test, the incremental shuttle walk test and cardiopulmonary exercise testing were reported in three studies each. Other objective measures of exercise capacity included a submaximal treadmill test, the Naughton protocol treadmill test, cycle ergometer maximal test, endurance shuttle walk test, constant cycle work rate test, a peak work rate test and the number of flights of stairs a participant was able to walk without stopping. A number of participant self-reported measures of exercise capacity were noted. Only one study aimed to analyze the effects of an intensive fitness intervention on daily PA. One further study reported on an exercise intervention and objectively measured PA at baseline. No studies measured SB. The assessment of PA and use of PA as an intervention in AATD is limited, and research into SB absent. Future research should measure PA and SB levels in people with AATD and explore interventions to enhance PA in this susceptible population. CI - (c) 2023 O'Shea et al. FAU - O'Shea, Orlagh AU - O'Shea O AUID- ORCID: 0000-0003-2961-6717 AD - School of Physiotherapy, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin 2, Ireland. FAU - Casey, Saidhbhe AU - Casey S AD - School of Physiotherapy, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin 2, Ireland. FAU - Giblin, Ciaran AU - Giblin C AD - School of Physiotherapy, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin 2, Ireland. FAU - Stephenson, Aoife AU - Stephenson A AD - School of Physiotherapy, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin 2, Ireland. AD - School of Health Sciences, University of Southampton, Southampton, UK. FAU - Carroll, Tomas P AU - Carroll TP AD - Irish Centre for Genetic Lung Disease, Department of Medicine, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland. FAU - McElvaney, Noel G AU - McElvaney NG AD - Irish Centre for Genetic Lung Disease, Department of Medicine, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland. FAU - McDonough, Suzanne M AU - McDonough SM AD - School of Physiotherapy, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin 2, Ireland. AD - School of Health Sciences, University of Southampton, Southampton, UK. AD - Centre for Health and Rehabilitation Technologies, School of Health Sciences, Ulster University, Newtownabbey, BT37 0QB, UK. AD - School of Physiotherapy, University of Otago, Dunedin, New Zealand. LA - eng PT - Journal Article PT - Review DEP - 20230616 PL - New Zealand TA - Int J Chron Obstruct Pulmon Dis JT - International journal of chronic obstructive pulmonary disease JID - 101273481 RN - 0 (alpha 1-Antitrypsin) SB - IM MH - Humans MH - Sedentary Behavior MH - *Pulmonary Disease, Chronic Obstructive/diagnosis/therapy MH - Exercise Tolerance MH - Exercise MH - *alpha 1-Antitrypsin Deficiency/diagnosis/genetics/therapy MH - alpha 1-Antitrypsin PMC - PMC10281283 OTO - NOTNLM OT - AATD OT - COPD OT - exercise capacity OT - lung disease OT - physical activity measurement OT - sedentary behavior COIS- Professor Noel G McElvaney reports grants from Grifols, Csl Behring; advisory board for vertex and inhibrx, outside the submitted work. The authors report no other conflicts of interest in this work. EDAT- 2023/06/22 13:09 MHDA- 2023/06/26 06:41 PMCR- 2023/06/16 CRDT- 2023/06/22 09:45 PHST- 2022/09/15 00:00 [received] PHST- 2023/03/07 00:00 [accepted] PHST- 2023/06/26 06:41 [medline] PHST- 2023/06/22 13:09 [pubmed] PHST- 2023/06/22 09:45 [entrez] PHST- 2023/06/16 00:00 [pmc-release] AID - 389001 [pii] AID - 10.2147/COPD.S389001 [doi] PST - epublish SO - Int J Chron Obstruct Pulmon Dis. 2023 Jun 16;18:1231-1250. doi: 10.2147/COPD.S389001. eCollection 2023.